---
layout: minimal-medicine
nav_exclude: true
title: Ivabradine + Metoprolol Tartrate
---

# Ivabradine + Metoprolol Tartrate

**Generic Name:** Ivabradine + Metoprolol Tartrate (This is a hypothetical combination; no such fixed-dose combination is currently approved by major regulatory bodies like the FDA or EMA.  This information is for educational purposes only and should not be considered medical advice.)

**Usage:**  *(Hypothetical)*  This combination *would theoretically* be used to treat chronic stable angina (chest pain) and/or heart failure in patients who haven't adequately responded to either drug alone, or in whom the combined effects are deemed beneficial by a cardiologist.  It might be considered in cases where a reduction in both heart rate and blood pressure is desired.  **Crucially, this combination is NOT currently approved and should only be considered under strict medical supervision.**

**Side Effects:**  The side effects would be a combination of those seen with ivabradine and metoprolol tartrate individually, potentially amplified or modified by their interaction. These could include:

* **From Ivabradine:**  Bright flashes or shimmering lights (phosphenes), bradycardia (slow heart rate), atrial fibrillation (irregular heartbeat), dizziness, headache, nausea, constipation.
* **From Metoprolol Tartrate:**  Bradycardia, dizziness, lightheadedness, fatigue, shortness of breath, nausea, cold extremities, sleep disturbances, depression.
* **Combined Effects:**  The combined use *could* increase the risk of severe bradycardia (dangerously slow heart rate) and hypotension (low blood pressure).


**How it Works:**

* **Ivabradine:** Ivabradine selectively inhibits the If current in the sinoatrial (SA) node of the heart, slowing the heart rate without significantly affecting contractility. This leads to reduced oxygen demand by the heart muscle.
* **Metoprolol Tartrate:** Metoprolol tartrate is a beta-blocker that reduces the heart rate, reduces blood pressure, and decreases the force of heart contractions.  This lowers the workload on the heart and reduces oxygen demand.

The combination aims for a synergistic effect: Ivabradine primarily targets the heart rate, while Metoprolol affects both heart rate and blood pressure, potentially providing more comprehensive control of symptoms in specific patient populations.


**FAQs:**

* **Is this combination FDA-approved?** No.  While both ivabradine and metoprolol tartrate are approved individually, there is no approved fixed-dose combination.  This combination must *never* be initiated or adjusted without the explicit direction of a physician.
* **Who should not use this (hypothetical) combination?** Patients with sick sinus syndrome, severe bradycardia, second- or third-degree atrioventricular block (unless a pacemaker is in place), cardiogenic shock, severe hypotension, or certain other heart conditions.  Also, individuals with severe respiratory problems or metabolic acidosis should use caution.
* **What are the risks of taking this combination?**  The primary risk is severe bradycardia and hypotension.  Regular monitoring of heart rate and blood pressure is crucial.
* **How is this combination administered?**  This would require separate administration of each drug; there is no single combined pill. The dosages would be carefully determined by a cardiologist.
* **Can I take this combination with other medications?**  Interactions with other medications are possible.  This must be discussed with a doctor before initiating any treatment.


**Disclaimer:** This information is for educational purposes only and should not be construed as medical advice.  Always consult with a qualified healthcare professional before starting, stopping, or altering any medication regimen.  The hypothetical combination described here is not currently available or approved for use.


**Note:** This information is AI-generated or crowd-sourced and may not be accurate. Please consult a medical professional for verified advice.